Who makes Computer controlled 4% articaine delivery by Anaeject?

Computer controlled 4% articaine delivery by Anaeject is developed by University of Belgrade.

What development phase is Computer controlled 4% articaine delivery by Anaeject in?

Computer controlled 4% articaine delivery by Anaeject is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Computer controlled 4% articaine delivery by Anaeject

University of Belgrade · FDA-approved active Small molecule Quality 0/100

At a glance

Generic name	Computer controlled 4% articaine delivery by Anaeject
Sponsor	University of Belgrade
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Effects of Articaine Computer-controlled and Conventional Delivery for Anterior and Middle Superior Alveolar Nerve Block for Tooth Extraction (PHASE4)
Effects of Articaine Computer-controlled and Conventional Delivery for Anterior and Middle Superior Alveolar Nerve Block (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Computer controlled 4% articaine delivery by Anaeject CI brief — competitive landscape report
Computer controlled 4% articaine delivery by Anaeject updates RSS · CI watch RSS
University of Belgrade portfolio CI